Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.12 trillion and total revenue of $109.99 billion.
Market Cap
1.12T
Revenue
109.99B
Profits
-41.27B
PE Ratio
n/a
Profit Margin
-37.52%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 109.75B | 0.46% | 561,343 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 65.76B | -0.52% | 492,574 | 14.92B |
| 3 | ARGX | argenx SE | 49.93B | 2.42% | 149,325 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.20B | 0.87% | 215,635 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 34.64B | 0.93% | 120,776 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 32.67B | 2.23% | 1,028,600 | - |
| 7 | RPRX | Royalty Pharma plc | 30.61B | 0.19% | 1,230,660 | 2.44B |
| 8 | INSM | Insmed Incorporated | 23.74B | 1.50% | 1,705,717 | 819.56M |
| 9 | BNTX | BioNTech SE | 23.17B | 1.39% | 359,897 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 22.56B | -3.21% | 4,509,384 | 8.26M |
| 11 | INCY | Incyte Corporation | 19.52B | 0.64% | 303,933 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.83B | -1.37% | 2,504,354 | 2.23B |
| 13 | GMAB | Genmab A/S | 16.45B | -0.22% | 626,335 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 15.20B | 1.37% | 206,635 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.07B | 0.49% | 256,577 | 4.44B |
| 16 | SMMT | Summit Therapeutics Inc. | 13.88B | -0.06% | 1,256,192 | - |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.82B | 3.43% | 1,088,927 | 579.96M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.54B | 1.08% | 664,538 | 1.06B |
| 19 | EXEL | Exelixis, Inc. | 12.54B | -0.06% | 698,071 | 2.38B |
| 20 | AXSM | Axsome Therapeutics, Inc. | 12.04B | 1.47% | 208,792 | 708.24M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.95B | 0.91% | 143,102 | 1.13B |
| 22 | CYTK | Cytokinetics, Incorporated | 10.65B | -0.38% | 843,713 | 105.82M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.58B | -2.66% | 628,984 | 622.01M |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 10.44B | 7.59% | 2,453,262 | 3.24B |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 9.68B | 3.51% | 94,639 | 7.46M |
| 26 | ABVX | ABIVAX Société Anonyme | 9.54B | 3.36% | 716,067 | 5.37M |
| 27 | KRYS | Krystal Biotech, Inc. | 9.00B | 1.09% | 76,699 | 417.30M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.12B | -0.75% | 750,204 | 1.51B |
| 29 | NUVL | Nuvalent, Inc. | 8.02B | -0.79% | 201,325 | - |
| 30 | IBRX | ImmunityBio, Inc. | 7.99B | -5.28% | 15,495,333 | 140.98M |
| 31 | TECH | Bio-Techne Corporation | 7.39B | 1.11% | 1,033,361 | 1.21B |
| 32 | CELC | Celcuity Inc. | 6.93B | 1.20% | 342,073 | - |
| 33 | IMVT | Immunovant, Inc. | 6.90B | -4.84% | 2,758,981 | - |
| 34 | PCVX | Vaxcyte, Inc. | 6.84B | 0.47% | 561,403 | - |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.63B | -0.11% | 149,506 | 51.48M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.60B | 1.70% | 144,436 | 74.06M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 6.40B | 2.42% | 435,692 | - |
| 38 | CORT | Corcept Therapeutics Incorporated | 6.39B | 0.80% | 312,655 | 769.10M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.27B | 1.00% | 141,153 | 217.17M |
| 40 | APGE | Apogee Therapeutics, Inc. | 6.20B | 1.56% | 200,018 | - |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 6.19B | 4.69% | 457,335 | 569.61M |
| 42 | CNTA | Centessa Pharmaceuticals plc | 6.16B | 0.15% | 1,374,688 | 15.00M |
| 43 | PTCT | PTC Therapeutics, Inc. | 5.81B | -1.34% | 376,259 | 827.11M |
| 44 | SRRK | Scholar Rock Holding Corporation | 5.72B | -1.34% | 598,703 | - |
| 45 | CGON | CG Oncology, Inc. | 5.70B | -0.12% | 375,040 | 5.07M |
| 46 | TGTX | TG Therapeutics, Inc. | 5.62B | -0.18% | 596,290 | 700.35M |
| 47 | COGT | Cogent Biosciences, Inc. | 5.61B | -0.26% | 586,085 | - |
| 48 | BLTE | Belite Bio, Inc | 5.49B | -2.59% | 86,532 | - |
| 49 | LEGN | Legend Biotech Corporation | 5.27B | 0.85% | 638,145 | 1.14B |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.27B | -0.35% | 388,216 | 7.50M |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 4.93B | 1.70% | 186,066 | 1.34M |
| 52 | CRSP | CRISPR Therapeutics AG | 4.78B | 2.16% | 770,628 | 4.10M |
| 53 | CAI | Caris Life Sciences, Inc. | 4.53B | 1.97% | 1,164,448 | 907.29M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.43B | 1.49% | 51,515 | 274.48M |
| 55 | NAMS | NewAmsterdam Pharma Company N.V. | 4.19B | 0.36% | 606,446 | 22.57M |
| 56 | MANE | Veradermics, Incorporated | 4.19B | -3.51% | 127,800 | - |
| 57 | TVTX | Travere Therapeutics, Inc. | 4.15B | 2.74% | 699,696 | 536.20M |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.91B | 2.18% | 328,290 | 18.07M |
| 59 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.26% | 1,289,023 | 596.96M |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 3.65B | 1.67% | 705,070 | 1.10B |
| 61 | ORKA | Oruka Therapeutics, Inc. | 3.64B | -0.61% | 784,917 | - |
| 62 | ERAS | Erasca, Inc. | 3.60B | 4.14% | 1,667,756 | - |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.54B | 3.60% | 1,154,525 | - |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.53B | -0.15% | 315,281 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.44B | -0.39% | 68,982 | 803.79M |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.20B | 5.08% | 1,293,181 | 56.99M |
| 67 | DNLI | Denali Therapeutics Inc. | 3.06B | 2.55% | 543,428 | - |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.02B | 1.22% | 149,886 | 236.00M |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.90B | -0.06% | 996,492 | - |
| 70 | ALMS | Alumis Inc. | 2.81B | -0.09% | 334,811 | 8.40M |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 2.77B | -0.49% | 106,533 | 535.08M |
| 72 | BEAM | Beam Therapeutics Inc. | 2.76B | 2.21% | 1,264,056 | 164.01M |
| 73 | RLAY | Relay Therapeutics, Inc. | 2.76B | 10.45% | 6,625,381 | 10.68M |
| 74 | KLRA | Kailera Therapeutics, Inc. | 2.72B | 4.53% | 177,605 | - |
| 75 | GPCR | Structure Therapeutics Inc. | 2.70B | 3.06% | 220,067 | - |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 2.61B | 1.95% | 579,627 | 415.62M |
| 77 | IDYA | IDEAYA Biosciences, Inc. | 2.60B | -0.03% | 249,224 | 225.27M |
| 78 | ELVN | Enliven Therapeutics, Inc. | 2.58B | 1.33% | 262,271 | - |
| 79 | IMNM | Immunome, Inc. | 2.58B | 5.90% | 890,060 | 4.02M |
| 80 | IRON | Disc Medicine, Inc. | 2.57B | 0.54% | 131,912 | - |
| 81 | VERA | Vera Therapeutics, Inc. | 2.48B | -0.35% | 272,015 | - |
| 82 | DFTX | Definium Therapeutics, Inc. | 2.44B | 7.09% | 1,131,505 | - |
| 83 | MLYS | Mineralys Therapeutics, Inc. | 2.42B | 3.31% | 267,055 | - |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.42B | -0.19% | 399,883 | 865.00K |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.35B | 2.44% | 623,612 | 670.00M |
| 86 | NKTR | Nektar Therapeutics | 2.35B | 0.22% | 256,138 | 55.63M |
| 87 | KOD | Kodiak Sciences Inc. | 2.31B | 2.26% | 163,955 | - |
| 88 | ZLAB | Zai Lab Limited | 2.15B | 1.67% | 172,662 | 453.28M |
| 89 | NBTX | Nanobiotix S.A. | 2.08B | -8.09% | 93,384 | 38.27M |
| 90 | TRVI | Trevi Therapeutics, Inc. | 2.03B | 3.03% | 455,116 | - |
| 91 | AUPH | Aurinia Pharmaceuticals Inc. | 2.00B | -2.26% | 435,170 | 298.30M |
| 92 | TYRA | Tyra Biosciences, Inc. | 1.99B | 0.03% | 350,974 | - |
| 93 | PHVS | Pharvaris N.V. | 1.98B | 2.55% | 135,347 | - |
| 94 | ADMA | ADMA Biologics, Inc. | 1.97B | -0.47% | 1,678,166 | 509.86M |
| 95 | VRDN | Viridian Therapeutics, Inc. | 1.94B | -0.43% | 715,885 | 70.92M |
| 96 | MESO | Mesoblast Limited | 1.91B | 2.48% | 76,371 | 65.38M |
| 97 | AAPG | Ascentage Pharma Group International | 1.90B | 3.99% | 3,574 | 82.08M |
| 98 | SION | Sionna Therapeutics, Inc. | 1.87B | 4.58% | 128,547 | - |
| 99 | VCEL | Vericel Corporation | 1.85B | 2.37% | 229,164 | 292.09M |
| 100 | STOK | Stoke Therapeutics, Inc. | 1.85B | -2.16% | 170,875 | 32.08M |
| 101 | ZYME | Zymeworks Inc. | 1.84B | 1.65% | 220,647 | 81.26M |
| 102 | OCS | Oculis Holding AG | 1.83B | 10.68% | 751,028 | 1.40M |
| 103 | SRPT | Sarepta Therapeutics, Inc. | 1.81B | 0.41% | 990,060 | 2.18B |
| 104 | OCUL | Ocular Therapeutix, Inc. | 1.81B | 2.74% | 1,206,129 | 52.04M |
| 105 | LKFT | Lakefront Biotherapeutics NV | 1.80B | 1.46% | 91,822 | 1.20B |
| 106 | HRMY | Harmony Biosciences Holdings, Inc. | 1.78B | -1.78% | 233,458 | 899.11M |
| 107 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | -0.65% | 644,522 | 217.17M |
| 108 | NRIX | Nurix Therapeutics, Inc. | 1.76B | 3.78% | 492,878 | 71.78M |
| 109 | GENB | Generate Biomedicines, Inc. | 1.76B | 5.22% | 629,305 | 30.30M |
| 110 | ANAB | AnaptysBio, Inc. | 1.74B | -0.45% | 218,135 | 232.39M |
| 111 | RAPP | Rapport Therapeutics, Inc. | 1.74B | 1.65% | 151,901 | 20.00M |
| 112 | NTLA | Intellia Therapeutics, Inc. | 1.72B | 0.33% | 2,410,498 | 66.09M |
| 113 | CAPR | Capricor Therapeutics, Inc. | 1.71B | 1.83% | 472,442 | 11.13M |
| 114 | AGIO | Agios Pharmaceuticals, Inc. | 1.70B | 0.14% | 229,609 | 66.05M |
| 115 | PVLA | Palvella Therapeutics, Inc. | 1.66B | 0.35% | 67,613 | - |
| 116 | RXRX | Recursion Pharmaceuticals, Inc. | 1.66B | 5.74% | 8,759,412 | 66.41M |
| 117 | NUVB | Nuvation Bio Inc. | 1.63B | 3.88% | 2,042,224 | 143.05M |
| 118 | IOVA | Iovance Biotherapeutics, Inc. | 1.63B | 3.11% | 6,150,076 | 285.61M |
| 119 | INVA | Innoviva, Inc. | 1.63B | -0.85% | 377,851 | 420.69M |
| 120 | TSHA | Taysha Gene Therapies, Inc. | 1.61B | 2.28% | 882,120 | 7.47M |
| 121 | GLUE | Monte Rosa Therapeutics, Inc. | 1.61B | 2.20% | 390,068 | 42.95M |
| 122 | INBX | Inhibrx Biosciences, Inc. | 1.61B | -0.45% | 149,831 | 1.30M |
| 123 | ATAI | AtaiBeckley Inc. | 1.57B | 4.40% | 2,222,761 | 3.49M |
| 124 | ABCL | AbCellera Biologics Inc. | 1.56B | 11.93% | 11,535,865 | 79.21M |
| 125 | ARDX | Ardelyx, Inc. | 1.55B | 0.16% | 1,144,466 | 427.68M |
| 126 | QURE | uniQure N.V. | 1.54B | -0.87% | 406,580 | 18.09M |
| 127 | PGEN | Precigen, Inc. | 1.53B | 0.47% | 1,108,014 | 31.60M |
| 128 | GHRS | GH Research PLC | 1.53B | -1.24% | 196,075 | - |
| 129 | VIR | Vir Biotechnology, Inc. | 1.52B | 1.69% | 398,969 | 65.50M |
| 130 | IMCR | Immunocore Holdings plc | 1.52B | 1.25% | 170,735 | 412.81M |
| 131 | MBX | MBX Biosciences, Inc. | 1.51B | 1.02% | 257,230 | - |
| 132 | DMRA | Damora Therapeutics, Inc. | 1.50B | 2.94% | 122,769 | - |
| 133 | NVAX | Novavax, Inc. | 1.50B | -1.83% | 2,207,556 | 596.34M |
| 134 | IMTX | Immatics N.V. | 1.49B | -0.89% | 238,395 | 43.00M |
| 135 | URGN | UroGen Pharma Ltd. | 1.48B | 0.26% | 267,081 | 140.49M |
| 136 | BHVN | Biohaven Ltd. | 1.43B | 7.12% | 1,224,933 | - |
| 137 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | -0.07% | 993,599 | 114.48M |
| 138 | MAZE | Maze Therapeutics, Inc. | 1.42B | 2.40% | 193,138 | 20.00M |
| 139 | BCAX | Bicara Therapeutics Inc. | 1.38B | 3.03% | 167,679 | - |
| 140 | SLS | SELLAS Life Sciences Group, Inc. | 1.34B | -19.90% | 19,893,879 | - |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.32B | 6.45% | 318,725 | - |
| 142 | SVRA | Savara Inc. | 1.29B | 0.20% | 383,502 | - |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.29B | 1.62% | 238,650 | - |
| 144 | MPLT | MapLight Therapeutics, Inc. | 1.28B | 1.51% | 54,316 | - |
| 145 | FTRE | Fortrea Holdings Inc. | 1.26B | -2.85% | 449,110 | 2.71B |
| 146 | ZBIO | Zenas BioPharma, Inc. | 1.25B | 1.38% | 202,981 | 10.00M |
| 147 | SEPN | Septerna, Inc. | 1.25B | -1.11% | 96,515 | 72.26M |
| 148 | OLMA | Olema Pharmaceuticals, Inc. | 1.24B | 1.50% | 404,541 | - |
| 149 | WVE | Wave Life Sciences Ltd. | 1.22B | 2.83% | 2,103,550 | 71.80M |
| 150 | AVLN | Avalyn Pharma Inc. | 1.18B | 0.57% | 104,795 | - |
| 151 | JBIO | Jade Biosciences, Inc. | 1.18B | 2.27% | 218,269 | - |
| 152 | COAG | Hemab Therapeutics Holdings, Inc. | 1.17B | -0.26% | 45,645 | - |
| 153 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.13B | -0.90% | 1,314,610 | 204.73M |
| 154 | DBVT | DBV Technologies S.A. | 1.11B | 0.81% | 111,945 | 5.74M |
| 155 | EYPT | EyePoint, Inc. | 1.09B | 3.60% | 273,165 | 7.61M |
| 156 | CRVS | Corvus Pharmaceuticals, Inc. | 1.08B | 4.92% | 1,051,938 | - |
| 157 | IVA | Inventiva S.A. | 1.07B | 1.36% | 56,456 | 7.94M |
| 158 | AKTS | Aktis Oncology, Inc. | 1.06B | 0.32% | 80,107 | 8.28M |
| 159 | MNKD | MannKind Corporation | 1.01B | 0.46% | 1,643,453 | 360.78M |
| 160 | KURA | Kura Oncology, Inc. | 1.00B | 9.28% | 3,225,959 | 71.64M |
| 161 | LXRX | Lexicon Pharmaceuticals, Inc. | 979.25M | -0.23% | 1,150,122 | 69.64M |
| 162 | DRTS | Alpha Tau Medical Ltd. | 976.91M | -0.72% | 504,945 | - |
| 163 | PHAT | Phathom Pharmaceuticals, Inc. | 922.98M | -2.11% | 272,573 | 204.89M |
| 164 | SPTX | Seaport Therapeutics, Inc. | 917.38M | 9.63% | 123,387 | - |
| 165 | PHAR | Pharming Group N.V. | 911.66M | -1.24% | 5,351 | 369.49M |
| 166 | ORIC | ORIC Pharmaceuticals, Inc. | 895.43M | 2.85% | 273,520 | - |
| 167 | OMER | Omeros Corporation | 893.84M | -0.24% | 568,680 | 9.89M |
| 168 | MGTX | MeiraGTx Holdings plc | 889.98M | 0.31% | 203,809 | 79.76M |
| 169 | JANX | Janux Therapeutics, Inc. | 883.05M | 0.56% | 324,501 | 13.73M |
| 170 | ABUS | Arbutus Biopharma Corporation | 881.02M | 2.06% | 1,301,441 | 191.45M |
| 171 | SANA | Sana Biotechnology, Inc. | 876.62M | 1.29% | 889,659 | - |
| 172 | CGEM | Cullinan Therapeutics, Inc. | 862.87M | -2.02% | 342,175 | - |
| 173 | AURA | Aura Biosciences, Inc. | 853.72M | 3.61% | 480,190 | - |
| 174 | TBPH | Theravance Biopharma, Inc. | 849.59M | -0.42% | 113,375 | 109.78M |
| 175 | ANNX | Annexon, Inc. | 848.70M | 2.78% | 1,014,936 | - |
| 176 | ODTX | Odyssey Therapeutics, Inc. | 848.66M | 6.04% | 287,672 | 2.98M |
| 177 | EVMN | Evommune, Inc. | 848.23M | 5.70% | 324,559 | 10.00M |
| 178 | XNCR | Xencor, Inc. | 841.51M | 0.27% | 300,540 | 97.36M |
| 179 | AVTX | Avalo Therapeutics, Inc. | 826.60M | 3.44% | 749,688 | 59.00K |
| 180 | SPRY | ARS Pharmaceuticals, Inc. | 822.23M | 6.15% | 1,101,984 | 98.99M |
| 181 | CTMX | CytomX Therapeutics, Inc. | 821.83M | 1.48% | 852,230 | 35.54M |
| 182 | VOR | Vor Biopharma Inc. | 817.66M | -2.96% | 564,977 | - |
| 183 | GERN | Geron Corporation | 811.52M | 0.40% | 4,985,043 | 196.12M |
| 184 | LBRX | LB Pharmaceuticals Inc | 810.98M | 0.89% | 54,851 | - |
| 185 | ABSI | Absci Corporation | 806.03M | 4.44% | 1,768,531 | 1.84M |
| 186 | DRUG | Bright Minds Biosciences Inc. | 798.70M | 1.35% | 318,855 | - |
| 187 | RLMD | Relmada Therapeutics, Inc. | 767.78M | 2.09% | 403,177 | - |
| 188 | SGP | SpyGlass Pharma, Inc. | 744.41M | 1.74% | 43,179 | - |
| 189 | ANRO | Alto Neuroscience, Inc. | 741.01M | 1.73% | 129,469 | - |
| 190 | TENX | Tenax Therapeutics, Inc. | 720.96M | 2.04% | 183,331 | - |
| 191 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 719.50M | 2.04% | 198,584 | - |
| 192 | DSGN | Design Therapeutics, Inc. | 697.64M | 0.63% | 819,814 | - |
| 193 | ALLO | Allogene Therapeutics, Inc. | 671.33M | 2.37% | 2,881,294 | 22.00K |
| 194 | CBIO | Crescent Biopharma, Inc. | 665.91M | 5.98% | 71,398 | 11.88M |
| 195 | SLDB | Solid Biosciences Inc. | 645.83M | 1.39% | 267,180 | - |
| 196 | ACRS | Aclaris Therapeutics, Inc. | 639.66M | 1.10% | 224,275 | 8.37M |
| 197 | CRMD | CorMedix Inc. | 625.26M | 0.50% | 705,568 | 400.05M |
| 198 | ZVRA | Zevra Therapeutics, Inc. | 615.39M | 1.66% | 1,600,562 | 122.29M |
| 199 | EIKN | Eikon Therapeutics, Inc. | 609.06M | 5.53% | 92,976 | - |
| 200 | CABA | Cabaletta Bio, Inc. | 606.55M | 8.14% | 2,468,041 | - |
| 201 | ARVN | Arvinas, Inc. | 594.89M | 1.32% | 416,009 | 89.40M |
| 202 | CADL | Candel Therapeutics, Inc. | 589.46M | 4.35% | 1,056,739 | - |
| 203 | TRAX | First Tracks Biotherapeutics, Inc. | 573.98M | 1.76% | 151,221 | - |
| 204 | GYRE | Gyre Therapeutics, Inc. | 561.94M | 1.82% | 63,274 | 117.05M |
| 205 | ALT | Altimmune, Inc. | 560.09M | 2.13% | 1,642,142 | 36.00K |
| 206 | VALN | Valneva SE | 549.16M | -2.36% | 8,790 | 180.25M |
| 207 | RIGL | Rigel Pharmaceuticals, Inc. | 547.11M | 2.60% | 105,326 | 299.77M |
| 208 | TECX | Tectonic Therapeutic, Inc. | 543.24M | -0.17% | 38,720 | - |
| 209 | MDXG | MiMedx Group, Inc. | 542.91M | -3.83% | 832,730 | 389.42M |
| 210 | AGMB | AgomAb Therapeutics NV | 537.79M | 2.06% | 13,655 | - |
| 211 | KYTX | Kyverna Therapeutics, Inc. | 536.90M | 3.50% | 519,130 | - |
| 212 | PRME | Prime Medicine, Inc. | 531.02M | 3.89% | 1,389,006 | 4.03M |
| 213 | PROK | ProKidney Corp. | 529.94M | 3.85% | 574,404 | 889.00K |
| 214 | FBRX | Forte Biosciences, Inc. | 529.03M | 6.60% | 82,355 | - |
| 215 | CTNM | Contineum Therapeutics, Inc. | 526.77M | 5.23% | 73,129 | - |
| 216 | STRO | Sutro Biopharma, Inc. | 525.53M | 1.90% | 189,300 | 99.61M |
| 217 | XOMA | XOMA Royalty Corporation | 524.72M | -0.33% | 31,805 | 48.56M |
| 218 | DNA | Ginkgo Bioworks Holdings, Inc. | 520.64M | 3.24% | 277,707 | 151.40M |
| 219 | CLYM | Climb Bio, Inc. | 517.81M | 3.04% | 373,822 | - |
| 220 | ACHV | Achieve Life Sciences, Inc. | 484.55M | 3.28% | 490,134 | - |
| 221 | PRTA | Prothena Corporation plc | 484.27M | -1.07% | 169,731 | 57.94M |
| 222 | ANL | Adlai Nortye Ltd. | 478.60M | 5.33% | 62,755 | 5.00M |
| 223 | UPB | Upstream Bio, Inc. | 464.20M | 1.43% | 356,252 | 3.32M |
| 224 | OCGN | Ocugen, Inc. | 462.08M | 0.37% | 1,931,175 | 4.47M |
| 225 | FDMT | 4D Molecular Therapeutics, Inc. | 457.42M | 3.31% | 316,839 | 88.24M |
| 226 | STTK | Shattuck Labs, Inc. | 456.89M | -2.03% | 364,015 | 1.00M |
| 227 | IMMX | Immix Biopharma, Inc. | 452.19M | -4.59% | 4,743,254 | - |
| 228 | VTVT | vTv Therapeutics Inc. | 448.73M | -1.20% | 17,000 | 36.84M |
| 229 | SGMT | Sagimet Biosciences Inc. | 445.54M | 8.50% | 404,906 | - |
| 230 | PRLD | Prelude Therapeutics Incorporated | 444.86M | -1.71% | 144,661 | 16.72M |
| 231 | AUTL | Autolus Therapeutics plc | 444.46M | 3.09% | 431,358 | 92.62M |
| 232 | NGNE | Neurogene Inc. | 438.66M | 3.01% | 76,225 | 925.00K |
| 233 | FULC | Fulcrum Therapeutics, Inc. | 435.18M | 2.85% | 172,854 | 80.00M |
| 234 | ADCT | ADC Therapeutics SA | 432.45M | 4.94% | 415,309 | 79.18M |
| 235 | REPL | Replimune Group, Inc. | 428.55M | 0.58% | 1,804,016 | - |
| 236 | OVID | Ovid Therapeutics Inc. | 422.21M | 2.09% | 504,536 | 7.12M |
| 237 | MNPR | Monopar Therapeutics Inc. | 415.46M | -4.51% | 124,508 | - |
| 238 | ASMB | Assembly Biosciences, Inc. | 415.11M | -0.53% | 28,360 | 71.10M |
| 239 | LXEO | Lexeo Therapeutics, Inc. | 414.99M | 3.22% | 377,070 | - |
| 240 | IPSC | Century Therapeutics, Inc. | 414.81M | 2.22% | 294,809 | 109.16M |
| 241 | LYEL | Lyell Immunopharma, Inc. | 412.75M | 2.73% | 24,477 | 31.00K |
| 242 | ZURA | Zura Bio Limited | 411.78M | 6.24% | 432,726 | - |
| 243 | ENTA | Enanta Pharmaceuticals, Inc. | 398.37M | 0.66% | 41,943 | 69.21M |
| 244 | EPRX | Eupraxia Pharmaceuticals Inc. | 391.13M | 12.40% | 189,104 | - |
| 245 | CCCC | C4 Therapeutics, Inc. | 388.94M | 7.62% | 1,256,926 | 34.86M |
| 246 | ARTV | Artiva Biotherapeutics, Inc. | 388.71M | 2.04% | 324,539 | 251.00K |
| 247 | BNTC | Benitec Biopharma Inc. | 387.52M | 2.64% | 19,749 | - |
| 248 | XFOR | X4 Pharmaceuticals, Inc. | 380.11M | 6.90% | 154,414 | 9.01M |
| 249 | VSTM | Verastem, Inc. | 376.98M | 3.87% | 2,035,986 | 49.59M |
| 250 | IFRX | InflaRx N.V. | 374.12M | 4.10% | 251,388 | 33.82K |
| 251 | VNDA | Vanda Pharmaceuticals Inc. | 373.44M | 0.49% | 286,964 | 217.78M |
| 252 | OABI | OmniAb, Inc. | 371.13M | -0.78% | 419,414 | 28.94M |
| 253 | GLSI | Greenwich LifeSciences, Inc. | 369.92M | -2.27% | 35,465 | - |
| 254 | LRMR | Larimar Therapeutics, Inc. | 367.43M | -0.28% | 964,953 | - |
| 255 | PBYI | Puma Biotechnology, Inc. | 356.30M | 0.14% | 68,812 | 227.18M |
| 256 | CMPX | Compass Therapeutics, Inc. | 351.17M | 3.17% | 4,071,646 | 850.00K |
| 257 | RZLT | Rezolute, Inc. | 347.87M | 3.42% | 485,431 | - |
| 258 | RCKT | Rocket Pharmaceuticals, Inc. | 343.96M | 6.06% | 2,005,980 | - |
| 259 | FENC | Fennec Pharmaceuticals Inc. | 342.85M | 1.23% | 111,698 | 51.00M |
| 260 | AVIR | Atea Pharmaceuticals, Inc. | 336.91M | 0.48% | 226,121 | - |
| 261 | IMRX | Immuneering Corporation | 336.43M | 3.59% | 355,215 | - |
| 262 | PALI | Palisade Bio, Inc. | 334.85M | 6.38% | 5,018,411 | - |
| 263 | NMRA | Neumora Therapeutics, Inc. | 334.32M | 6.40% | 554,697 | - |
| 264 | RGNX | REGENXBIO Inc. | 332.42M | 7.71% | 1,641,192 | 87.82M |
| 265 | LCTX | Lineage Cell Therapeutics, Inc. | 330.32M | 2.71% | 364,239 | 14.78M |
| 266 | YDES | YD Bio Limited | 325.58M | 1.76% | 5,579 | 510.36K |
| 267 | SRZN | Surrozen, Inc. | 319.45M | 2.81% | 26,398 | 7.49M |
| 268 | IVVD | Invivyd, Inc. | 318.15M | 3.21% | 2,072,379 | 55.87M |
| 269 | ABEO | Abeona Therapeutics Inc. | 314.61M | 3.76% | 358,735 | 14.54M |
| 270 | DMAC | DiaMedica Therapeutics Inc. | 314.14M | 1.92% | 57,658 | - |
| 271 | BCYC | Bicycle Therapeutics plc | 312.98M | 1.58% | 177,274 | 63.50M |
| 272 | IRD | Opus Genetics, Inc. | 312.03M | -1.58% | 402,931 | 11.98M |
| 273 | NAUT | Nautilus Biotechnology, Inc. | 308.17M | 1.89% | 294,787 | - |
| 274 | SLN | Silence Therapeutics plc | 304.66M | 3.37% | 75,280 | 839.00K |
| 275 | NAGE | Niagen Bioscience, Inc. | 303.68M | 1.47% | 501,345 | 130.42M |
| 276 | ELDN | Eledon Pharmaceuticals, Inc. | 303.03M | 2.08% | 575,244 | - |
| 277 | NGEN | NervGen Pharma Corp. | 301.84M | -0.28% | 25,915 | - |
| 278 | ARMP | Armata Pharmaceuticals, Inc. | 301.63M | 1.23% | 30,147 | 5.20M |
| 279 | IKT | Inhibikase Therapeutics, Inc. | 298.24M | 4.17% | 531,920 | 1.00 |
| 280 | NVCT | Nuvectis Pharma, Inc. | 292.18M | 3.62% | 29,818 | - |
| 281 | ACIU | AC Immune SA | 283.72M | -1.04% | 107,589 | 4.62M |
| 282 | TARA | Protara Therapeutics, Inc. | 281.58M | 5.25% | 1,340,626 | - |
| 283 | ZNTL | Zentalis Pharmaceuticals, Inc. | 279.41M | 5.80% | 392,231 | 26.87M |
| 284 | MGNX | MacroGenics, Inc. | 275.85M | -2.69% | 554,851 | 157.08M |
| 285 | CLLS | Cellectis S.A. | 268.62M | -3.01% | 30,932 | 75.11M |
| 286 | ALXO | ALX Oncology Holdings Inc. | 268.45M | 0.25% | 302,171 | - |
| 287 | EDIT | Editas Medicine, Inc. | 260.43M | 2.31% | 638,490 | 38.69M |
| 288 | SABS | SAB Biotherapeutics, Inc. | 259.67M | 0.41% | 203,293 | 114.70K |
| 289 | NERV | Minerva Neurosciences, Inc. | 257.17M | 9.74% | 89,490 | - |
| 290 | AVXL | Anavex Life Sciences Corp. | 256.24M | 0.55% | 509,714 | - |
| 291 | ADAG | Adagene Inc. | 249.42M | 9.42% | 127,072 | 7.67M |
| 292 | CGEN | Compugen Ltd. | 246.87M | -3.51% | 314,264 | 72.66M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 246.11M | 3.27% | 229,590 | 32.72M |
| 294 | CHRS | Coherus Oncology, Inc. | 244.49M | 4.97% | 841,005 | 46.88M |
| 295 | LENZ | LENZ Therapeutics, Inc. | 243.94M | 8.06% | 327,069 | 20.99M |
| 296 | FATE | Fate Therapeutics, Inc. | 242.44M | 13.04% | 3,278,627 | 6.32M |
| 297 | ALEC | Alector, Inc. | 239.81M | 1.89% | 529,994 | 18.42M |
| 298 | FHTX | Foghorn Therapeutics Inc. | 239.55M | 2.00% | 48,102 | 28.22M |
| 299 | CAMP | Camp4 Therapeutics Corporation | 236.52M | 1.22% | 37,583 | 3.93M |
| 300 | HELP | Cybin Inc. | 230.67M | 6.22% | 719,138 | - |
| 301 | TNXP | Tonix Pharmaceuticals Holding Corp. | 228.43M | -1.17% | 178,523 | 17.56M |
| 302 | HUMA | Humacyte, Inc. | 226.46M | 11.21% | 5,164,362 | 2.02M |
| 303 | KROS | Keros Therapeutics, Inc. | 225.82M | 3.92% | 182,778 | 33.18M |
| 304 | TRDA | Entrada Therapeutics, Inc. | 225.21M | 3.48% | 164,810 | 5.74M |
| 305 | CDXS | Codexis, Inc. | 224.51M | -4.26% | 380,812 | 78.09M |
| 306 | RNA | Atrium Therapeutics, Inc. | 223.40M | 2.67% | 142,174 | 36.68M |
| 307 | SLGL | Sol-Gel Technologies Ltd. | 220.98M | 3.54% | 57,038 | 19.39M |
| 308 | BDTX | Black Diamond Therapeutics, Inc. | 220.61M | 6.94% | 2,819,647 | 70.00M |
| 309 | CNTX | Context Therapeutics Inc. | 219.59M | 7.17% | 378,832 | - |
| 310 | NKTX | Nkarta, Inc. | 218.21M | 8.93% | 402,395 | - |
| 311 | VYGR | Voyager Therapeutics, Inc. | 218.12M | 3.14% | 246,373 | 36.49M |
| 312 | MDWD | MediWound Ltd. | 217.20M | 0.06% | 14,761 | 16.96M |
| 313 | IPHA | Innate Pharma S.A. | 213.87M | -9.09% | 41,219 | 10.57M |
| 314 | WHWK | Whitehawk Therapeutics, Inc. | 213.53M | 2.37% | 103,012 | 7.15M |
| 315 | NBP | NovaBridge Biosciences | 208.17M | 2.27% | 370,499 | - |
| 316 | MIST | Milestone Pharmaceuticals Inc. | 207.48M | 1.67% | 687,208 | 1.78M |
| 317 | TLSA | Tiziana Life Sciences Ltd | 204.20M | -0.62% | 878,165 | - |
| 318 | UNCY | Unicycive Therapeutics, Inc. | 203.72M | -1.42% | 436,776 | - |
| 319 | ARCT | Arcturus Therapeutics Holdings Inc. | 201.52M | 3.96% | 204,802 | 54.71M |
| 320 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 199.54M | 15.62% | 443,246 | - |
| 321 | RNAC | Cartesian Therapeutics, Inc. | 195.68M | 2.15% | 77,820 | 1.78M |
| 322 | CRBU | Caribou Biosciences, Inc. | 190.62M | -3.00% | 847,248 | 11.20M |
| 323 | CNTN | Canton Strategic Holdings, Inc. | 189.80M | 3.08% | 154,976 | - |
| 324 | PLYX | Polaryx Therapeutics, Inc. | 188.19M | 17.60% | 246,432 | - |
| 325 | DTIL | Precision BioSciences, Inc. | 186.29M | 0.56% | 83,338 | 45.07M |
| 326 | ELTX | Elicio Therapeutics, Inc. | 184.33M | 0.50% | 77,154 | - |
| 327 | KPTI | Karyopharm Therapeutics Inc. | 183.79M | 2.13% | 275,983 | 151.12M |
| 328 | ABOS | Acumen Pharmaceuticals, Inc. | 178.40M | 5.11% | 310,298 | - |
| 329 | ORMP | Oramed Pharmaceuticals Inc. | 177.15M | 2.34% | 45,990 | 2.00M |
| 330 | TNYA | Tenaya Therapeutics, Inc. | 172.84M | -1.44% | 1,640,347 | 225.00K |
| 331 | ENLV | Enlivex Ltd. | 172.35M | 1.63% | 79,402 | - |
| 332 | ANTX | AN2 Therapeutics, Inc. | 171.34M | 3.70% | 69,032 | - |
| 333 | GALT | Galectin Therapeutics Inc. | 166.54M | 14.48% | 247,840 | - |
| 334 | OKUR | OnKure Therapeutics, Inc. | 166.03M | 15.45% | 221,102 | - |
| 335 | HRTX | Heron Therapeutics, Inc. | 165.88M | 3.70% | 690,012 | 150.71M |
| 336 | IMUX | Immunic, Inc. | 165.16M | 4.98% | 181,570 | - |
| 337 | PLX | Protalix BioTherapeutics, Inc. | 164.77M | 1.74% | 404,904 | 76.38M |
| 338 | MENS | Jyong Biotech Ltd. | 160.03M | -4.10% | 12,781 | - |
| 339 | KRRO | Korro Bio, Inc. | 157.64M | 9.19% | 145,766 | 3.84M |
| 340 | SPRO | Spero Therapeutics, Inc. | 154.60M | 1.52% | 332,525 | 61.19M |
| 341 | KZIA | Kazia Therapeutics Limited | 153.12M | 3.32% | 82,409 | 1.27M |
| 342 | PRQR | ProQR Therapeutics N.V. | 152.25M | 1.05% | 459,343 | 15.73M |
| 343 | TTRX | Turn Therapeutics Inc. | 148.94M | 5.04% | 82,893 | - |
| 344 | HURA | TuHURA Biosciences, Inc. | 148.38M | -2.51% | 250,188 | - |
| 345 | GUTS | Fractyl Health, Inc. | 140.36M | -3.97% | 747,932 | 3.00K |
| 346 | SPRB | Spruce Biosciences, Inc. | 139.17M | -0.03% | 14,452 | 697.00K |
| 347 | MOLN | Molecular Partners AG | 138.78M | 4.28% | 14,274 | 856.30K |
| 348 | NTHI | NeOnc Technologies Holdings, Inc. | 136.26M | -0.20% | 12,461 | 39.99K |
| 349 | EQ | Equillium, Inc. | 135.94M | 4.37% | 140,676 | 4.39M |
| 350 | CNTB | Connect Biopharma Holdings Limited | 135.65M | 3.90% | 62,372 | 233.00K |
| 351 | AGEN | Agenus Inc. | 132.51M | 1.27% | 281,630 | 123.87M |
| 352 | GNLX | Genelux Corporation | 129.45M | -0.51% | 28,220 | 8.00K |
| 353 | PYXS | Pyxis Oncology, Inc. | 127.91M | 1.75% | 124,389 | 13.86M |
| 354 | ACOG | Alpha Cognition Inc. | 126.73M | -1.19% | 20,022 | 10.83M |
| 355 | CRDF | Cardiff Oncology, Inc. | 125.12M | -0.54% | 995,385 | 525.00K |
| 356 | ALPS | Alps Group Inc | 118.64M | 3.97% | 11,758 | 3.74M |
| 357 | KLRS | Kalaris Therapeutics, Inc. | 115.88M | 4.35% | 7,046 | - |
| 358 | ENGN | enGene Therapeutics Inc. | 114.55M | 6.21% | 924,076 | - |
| 359 | COYA | Coya Therapeutics, Inc. | 112.71M | 4.00% | 58,839 | 7.94M |
| 360 | CGTX | Cognition Therapeutics, Inc. | 112.59M | -2.33% | 649,098 | - |
| 361 | RANI | Rani Therapeutics Holdings, Inc. | 108.80M | - | 753,782 | 3.17M |
| 362 | INO | Inovio Pharmaceuticals, Inc. | 106.52M | 5.69% | 1,214,552 | 65.34K |
| 363 | PEPG | PepGen Inc. | 105.83M | 6.25% | 455,242 | - |
| 364 | CBUS | Cibus, Inc. | 105.27M | -2.82% | 91,549 | 4.29M |
| 365 | NRXP | NRx Pharmaceuticals, Inc. | 102.08M | 4.04% | 675,637 | 2.29M |
| 366 | VRCA | Verrica Pharmaceuticals Inc. | 101.18M | -2.16% | 20,334 | 37.16M |
| 367 | VANI | Vivani Medical, Inc. | 99.17M | -3.36% | 167,845 | - |
| 368 | BMEA | Biomea Fusion, Inc. | 99.05M | 3.01% | 594,910 | - |
| 369 | AARD | Aardvark Therapeutics, Inc. | 99.05M | 5.83% | 92,378 | - |
| 370 | SEER | Seer, Inc. | 98.45M | 3.87% | 104,102 | 15.17M |
| 371 | PMN | ProMIS Neurosciences, Inc. | 97.93M | 3.02% | 14,851 | - |
| 372 | EDSA | Edesa Biotech, Inc. | 96.68M | -0.46% | 167,610 | - |
| 373 | PYPD | PolyPid Ltd. | 94.46M | 2.06% | 164,301 | - |
| 374 | QTTB | Q32 Bio Inc. | 94.11M | -2.12% | 87,617 | 53.74M |
| 375 | ALDX | Aldeyra Therapeutics, Inc. | 94.10M | 0.65% | 297,547 | - |
| 376 | ONCY | Oncolytics Biotech Inc. | 94.06M | -1.22% | 239,117 | - |
| 377 | PTHS | Pelthos Therapeutics Inc. | 93.53M | -0.74% | 13,652 | 27.70M |
| 378 | LONA | LeonaBio, Inc. | 93.09M | 3.01% | 4,372 | - |
| 379 | ANIX | Anixa Biosciences, Inc. | 91.53M | - | 40,117 | - |
| 380 | ICCC | ImmuCell Corporation | 90.29M | 1.01% | 6,872 | 29.93M |
| 381 | FBIO | Fortress Biotech, Inc. | 90.19M | 2.45% | 377,515 | 66.16M |
| 382 | NRXS | NeurAxis, Inc. | 85.14M | 2.07% | 66,942 | 4.28M |
| 383 | OKYO | OKYO Pharma Limited | 85.02M | 1.25% | 9,794 | - |
| 384 | ACET | Adicet Bio, Inc. | 83.48M | 2.45% | 68,803 | - |
| 385 | RNTX | Rein Therapeutics Inc. | 81.55M | 7.78% | 426,809 | - |
| 386 | RLYB | Rallybio Corporation | 81.09M | 5.14% | 39,420 | 858.00K |
| 387 | ATRA | Atara Biotherapeutics, Inc. | 80.70M | 0.32% | 25,381 | 23.14M |
| 388 | CSBR | Champions Oncology, Inc. | 80.40M | -4.30% | 13,394 | 57.95M |
| 389 | EXOZ | eXoZymes, Inc. | 79.70M | - | 2,927 | -700.00 |
| 390 | HYFT | MindWalk Holdings Corp. | 78.47M | -0.63% | 554,633 | 20.70M |
| 391 | ACRV | Acrivon Therapeutics, Inc. | 77.90M | 3.41% | 143,216 | - |
| 392 | MAIA | MAIA Biotechnology, Inc. | 76.61M | -2.33% | 257,941 | - |
| 393 | MCRB | Seres Therapeutics, Inc. | 76.50M | 3.13% | 15,428 | 1.15M |
| 394 | PLRX | Pliant Therapeutics, Inc. | 76.47M | 2.92% | 171,080 | - |
| 395 | OSTX | OS Therapies Incorporated | 75.04M | -2.46% | 410,180 | - |
| 396 | GANX | Gain Therapeutics, Inc. | 74.43M | 5.76% | 345,891 | - |
| 397 | ANVS | Annovis Bio, Inc. | 73.80M | 4.41% | 893,168 | - |
| 398 | XBIT | XBiotech Inc. | 72.87M | - | 15,827 | - |
| 399 | IBIO | iBio, Inc. | 69.94M | 13.82% | 927,989 | 300.00K |
| 400 | ATHE | Alterity Therapeutics Limited | 69.76M | -0.47% | 18,280 | 4.43M |
| 401 | PMVP | PMV Pharmaceuticals, Inc. | 68.79M | -1.53% | 74,998 | - |
| 402 | LIXT | Lixte Biotechnology Holdings, Inc. | 67.73M | 4.11% | 124,831 | - |
| 403 | MNOV | MediciNova, Inc. | 67.43M | -1.44% | 6,993 | 596.64K |
| 404 | PDSB | PDS Biotechnology Corporation | 65.30M | 13.59% | 650,221 | - |
| 405 | CUE | Cue Biopharma, Inc. | 65.27M | -1.86% | 105,458 | 32.73M |
| 406 | IMMP | Immutep Limited | 63.02M | 2.58% | 172,917 | 5.28M |
| 407 | FLNA | Filana Therapeutics, Inc. | 62.08M | 2.80% | 124,325 | - |
| 408 | TCRX | TScan Therapeutics, Inc. | 61.90M | 3.56% | 142,696 | 9.14M |
| 409 | DWTX | Dogwood Therapeutics, Inc. | 60.79M | -1.09% | 30,443 | - |
| 410 | IMA | ImageneBio, Inc. | 60.57M | -0.74% | 6,366 | 800.00K |
| 411 | ENTX | Entera Bio Ltd. | 60.55M | -0.81% | 26,985 | 42.00K |
| 412 | BYSI | BeyondSpring Inc. | 60.51M | 2.19% | 9,368 | 1.88M |
| 413 | ACTU | Actuate Therapeutics, Inc. | 59.10M | -1.59% | 79,701 | - |
| 414 | CING | Cingulate Inc. | 58.07M | 2.38% | 176,495 | - |
| 415 | HYPD | Hyperion DeFi, Inc. | 56.11M | 4.50% | 802,101 | 1.04M |
| 416 | IBO | Impact BioMedical Inc. | 55.48M | -4.35% | 23,989 | 39.00K |
| 417 | TIL | Instil Bio, Inc. | 55.14M | 1.37% | 19,352 | - |
| 418 | INKT | MiNK Therapeutics, Inc. | 53.95M | 1.03% | 11,412 | - |
| 419 | ATYR | aTyr Pharma, Inc. | 52.51M | 0.92% | 1,826,648 | 190.00K |
| 420 | XLO | Xilio Therapeutics, Inc. | 51.66M | 2.31% | 7,134 | 53.48M |
| 421 | RADX | Radiopharm Theranostics Limited | 50.52M | 0.44% | 15,007 | 10.86M |
| 422 | ESLA | Estrella Immunopharma, Inc. | 49.70M | 2.19% | 10,446 | - |
| 423 | MGX | Metagenomi Therapeutics, Inc. | 48.75M | 0.39% | 138,079 | 22.33M |
| 424 | TVGN | Tevogen Bio Holdings Inc. | 47.78M | 8.87% | 18,921 | - |
| 425 | KALA | KALA BIO, Inc. | 47.78M | -3.02% | 51,903 | - |
| 426 | PSTV | Plus Therapeutics, Inc. | 47.42M | 7.47% | 242,070 | 5.18M |
| 427 | QNTM | Quantum BioPharma Ltd. | 46.49M | -0.38% | 347,096 | - |
| 428 | GOSS | Gossamer Bio, Inc. | 45.65M | -9.66% | 29,005,800 | 55.54M |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 43.49M | -3.44% | 68,732 | - |
| 430 | ATOS | Atossa Therapeutics, Inc. | 42.88M | 2.89% | 42,197 | - |
| 431 | MREO | Mereo BioPharma Group plc | 42.82M | -5.11% | 1,268,443 | 500.00K |
| 432 | NTRB | Nutriband Inc. | 42.42M | -1.13% | 7,888 | 2.04M |
| 433 | LITS | Lite Strategy, Inc. | 41.09M | 0.89% | 152,694 | - |
| 434 | RNXT | RenovoRx, Inc. | 38.97M | 6.76% | 344,974 | 1.49M |
| 435 | LTRN | Lantern Pharma Inc. | 38.67M | 8.83% | 140,427 | - |
| 436 | OTLK | Outlook Therapeutics, Inc. | 38.57M | 16.89% | 5,401,507 | 333.14K |
| 437 | NXTC | NextCure, Inc. | 37.92M | 8.97% | 16,183 | - |
| 438 | INMB | INmune Bio Inc. | 37.88M | 1.06% | 177,554 | 50.00K |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 37.08M | 1.67% | 58,851 | 90.00K |
| 440 | ALGS | Aligos Therapeutics, Inc. | 35.40M | 2.14% | 59,885 | 4.71M |
| 441 | DARE | Daré Bioscience, Inc. | 35.20M | 0.86% | 121,069 | 1.16M |
| 442 | VERU | Veru Inc. | 35.15M | 0.92% | 14,836 | 16.89M |
| 443 | NNVC | NanoViricides, Inc. | 35.08M | -4.94% | 450,373 | - |
| 444 | TVRD | Tvardi Therapeutics, Inc. | 34.99M | -3.12% | 27,481 | - |
| 445 | GRCE | Grace Therapeutics, Inc. | 34.51M | 2.29% | 95,035 | - |
| 446 | EVAX | Evaxion A/S | 33.25M | -0.32% | 6,252 | 7.53M |
| 447 | BOLD | Boundless Bio, Inc. | 32.62M | 2.46% | 16,379 | - |
| 448 | APLM | Apollomics, Inc. | 31.86M | 7.28% | 20,423 | 8.84M |
| 449 | SNTI | Senti Biosciences Holdings, Inc. | 31.14M | 2.03% | 194,248 | 38.00K |
| 450 | BRNS | Barinthus Biotherapeutics plc | 29.13M | 3.78% | 8,149 | 14.97M |
| 451 | CRVO | CervoMed Inc. | 28.70M | -4.32% | 36,145 | 2.09M |
| 452 | LSTA | Lisata Therapeutics, Inc. | 28.45M | -0.94% | 1,279 | 170.00K |
| 453 | IGC | IGC Pharma, Inc. | 27.87M | 0.37% | 171,541 | 1.11M |
| 454 | NRSN | NeuroSense Therapeutics Ltd. | 27.86M | -2.68% | 30,514 | - |
| 455 | KYNB | Kyntra Bio, Inc. | 27.69M | -1.58% | 2,448 | 7.44M |
| 456 | NEUP | Neuphoria Therapeutics Inc. | 27.60M | 3.85% | 49,100 | -13.27K |
| 457 | BCTX | BriaCell Therapeutics Corp. | 27.59M | -2.06% | 142,894 | - |
| 458 | DYAI | Dyadic International, Inc. | 26.96M | 0.33% | 6,585 | 3.81M |
| 459 | GRDX | GridAI Technologies Corp. | 26.51M | 11.33% | 92,013 | - |
| 460 | ABVC | ABVC BioPharma, Inc. | 26.44M | -2.73% | 53,571 | 797.92K |
| 461 | SKYE | Skye Bioscience, Inc. | 26.40M | -2.25% | 61,804 | - |
| 462 | PTN | Palatin Technologies, Inc. | 26.37M | -0.62% | 2,775 | 12.88M |
| 463 | ALLR | Allarity Therapeutics, Inc. | 25.82M | 12.08% | 368,862 | 345.00K |
| 464 | CELU | Celularity Inc. | 25.67M | 7.85% | 161,715 | 26.55M |
| 465 | TPST | Tempest Therapeutics, Inc. | 25.53M | -4.30% | 43,547 | - |
| 466 | CLRB | Cellectar Biosciences, Inc. | 25.41M | 0.32% | 80,821 | - |
| 467 | VTGN | Vistagen Therapeutics, Inc. | 25.38M | 0.13% | 131,266 | 789.00K |
| 468 | SER | Serina Therapeutics, Inc. | 25.18M | -0.59% | 25,243 | 130.00K |
| 469 | PLRZ | Polyrizon Ltd. | 25.12M | -0.96% | 15,606 | - |
| 470 | JSPR | Jasper Therapeutics, Inc. | 24.37M | -0.22% | 63,245 | - |
| 471 | SNSE | Sensei Biotherapeutics, Inc. | 23.83M | 1.14% | 9,166 | - |
| 472 | MRKR | Marker Therapeutics, Inc. | 23.34M | -0.71% | 37,110 | 3.55M |
| 473 | CMND | Clearmind Medicine Inc. | 23.23M | -9.52% | 115,019 | - |
| 474 | PLUR | Pluri Inc. | 23.21M | -11.20% | 20,777 | 1.08M |
| 475 | TRAW | Traws Pharma, Inc. | 22.73M | -7.41% | 457,618 | 2.73M |
| 476 | VYNE | VYNE Therapeutics Inc. | 22.38M | -0.75% | 63,965 | 454.00K |
| 477 | AEON | AEON Biopharma, Inc. | 21.88M | -3.60% | 14,337 | - |
| 478 | LGVN | Longeveron Inc. | 20.79M | 0.48% | 286,260 | 1.22M |
| 479 | HOWL | Werewolf Therapeutics, Inc. | 20.66M | -2.95% | 246,176 | 1.14M |
| 480 | CRIS | Curis, Inc. | 19.86M | 0.30% | 186,058 | 7.06M |
| 481 | HCWB | HCW Biologics Inc. | 18.65M | 13.99% | 17,374,434 | 6.59M |
| 482 | KTTA | Pasithea Therapeutics Corp. | 18.08M | 0.43% | 87,763 | - |
| 483 | CTXR | Citius Pharmaceuticals, Inc. | 17.71M | 12.64% | 626,328 | 5.61M |
| 484 | XCUR | Exicure, Inc. | 17.59M | -7.69% | 10,843 | 500.00K |
| 485 | LPCN | Lipocine Inc. | 17.41M | -3.13% | 31,371 | 2.00M |
| 486 | NCEL | NewcelX Ltd. | 17.09M | -2.31% | 2,300 | - |
| 487 | OSRH | OSR Holdings, Inc. | 16.89M | 2.00% | 557,832 | 2.63M |
| 488 | PASG | Passage Bio, Inc. | 16.63M | -0.29% | 6,159 | - |
| 489 | QNCX | Quince Therapeutics, Inc. | 16.63M | -5.56% | 542,960 | - |
| 490 | INAB | IN8bio, Inc. | 16.44M | 6.37% | 86,341 | - |
| 491 | CVKD | Cadrenal Therapeutics, Inc. | 16.35M | 2.91% | 32,402 | - |
| 492 | HIND | Vyome Holdings, Inc. | 16.14M | 8.99% | 26,607 | 152.72K |
| 493 | ICU | SeaStar Medical Holding Corporation | 15.75M | -0.76% | 32,864 | 1.44M |
| 494 | COCP | Cocrystal Pharma, Inc. | 15.58M | 1.80% | 27,209 | 225.00K |
| 495 | LEXX | Lexaria Bioscience Corp. | 15.10M | 4.78% | 84,751 | 368.00K |
| 496 | GDTC | CytoMed Therapeutics Limited | 14.55M | -6.82% | 5,214 | 669.28K |
| 497 | MTVA | MetaVia Inc. | 14.41M | -3.46% | 4,050,959 | - |
| 498 | GNTA | Genenta Science S.p.A. | 14.23M | -2.46% | 35,094 | - |
| 499 | ERNA | Ernexa Therapeutics Inc. | 14.11M | 6.14% | 127,127 | 1,000.00 |
| 500 | GTBP | GT Biopharma, Inc. | 13.56M | 2.50% | 763,384 | - |